Fluvastatin mitigates SARS-CoV-2 infection in human lung cells.

Although lovastatin, pravastatin, and rosuvastatin reduced HCoV-229E infection up to 15%, 25%, and 30%, respectively, the observations did not reach statistical significance in the cell culture assay.

also in 111,027 other papers